U.S. Immigration Data

Priority dates, work visas, and labor market data

BlueRock Therapeutics, LP

H-1B & Green Card Sponsorship Data

Source: US Dept of Labor. Represents Base Salary only. Excludes RSUs, signing bonuses, and variable compensation. View All Salary Records

6

Total Filings

2021-Present

100.0%

Approval Rate

Certified Cases

$173,500

Median Salary

Across All Roles
Filings by Program
5
H-1B Filings
1
PERM Filings
Labor certification, the first green card step
Recent Filing Activity
By Program Type
Program Last Filing Total (2021–Present)
H-1B Apr 24, 2026 5
PERM May 1, 2025 1
By Role (Most Recent)
Role Last Filing Total (2021–Present)
Research Director Apr 24, 2026 1
Clinical Trial Coordinator May 1, 2025 1
Specialist II, Lab Operations Jun 30, 2023 1
Principal Scientist, Genome Engineering May 25, 2022 1
Senior Medical Director, Neurology Dec 10, 2021 2
Top Roles by Filings
Role Count Median Salary Min Max
Senior Medical Director, Neurology 2 $287,015 $287,015 $287,015
Clinical Trial Coordinator 1 $123,000 $123,000 $123,000
Principal Scientist, Genome Engineering 1 $155,000 $155,000 $155,000
Research Director 1 $192,000 $192,000 $192,000
Specialist II, Lab Operations 1 $85,500 $85,500 $85,500
Salary Distribution (All Filings + Role Overlays)
10th Percentile

$104,250

25th Percentile

$131,000

Median (50th)

$173,500

75th Percentile

$263,261

90th Percentile

$287,015

Loading chart...
Loading chart...
Filings by State (Chart)
Loading chart...
Loading chart...
Median Salary by State (Chart)
Loading chart...
Loading chart...
Filing Volume Trend
Loading chart...
Loading chart...
Median Salary Trend
Loading chart...
Loading chart...
Filing Pace by Program
Loading chart...
Loading chart...
Year-over-Year Statistics
Fiscal Year Filings Median Salary Approval Rate
2021 1 $287,015 100.0%
2022 2 $221,008 100.0%
2023 1 $85,500 100.0%
2026 2 $157,500 100.0%
Data Source: U.S. Department of Labor (DOL) H-1B and green card (PERM) disclosure data. Represents Base Salary only (excludes RSUs, signing bonuses, and variable compensation). Data shown for fiscal years 2021 to present. Last updated: August 31, 2026